Centauri Therapeutics

Healthcare & Life Sciences

Recent Finacing

Non-dilutive financing

Recent Raise

$1.3M

Centauri Therapeutics develops immunotherapy treatments for infectious diseases using their Alphamer technology to target Gram-negative and Multi-Drug Resistant bacteria.

Total Funding

$1.3M

Headquarters

London, United Kingdom

Founded

N/A

Website

centauritherapeutics.com

Focus Areas

Immunotherapy

Infectious Diseases

Gram-negative Bacteria

Multi-Drug Resistant

Antibody Recruiting

Alphamer Technology

Investors